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Reactive gliosis is a generic response to Central Nervous System (CNS) injury mediated 
by astrocytes and microglia. Following ischemic damage to the CNS parenchyma, the injured 
area becomes surrounded by a dense astroglial cell layer known as glial scar. Glial scar 
formation has been recognized for many decades as a major impediment for neuronal 
reconnection and a serious obstacle for functional recovery. However, more recent studies 
have shown that scar limits the area of damage, preventing the diffusion of blood-derived 
activated immune cells into the CNS that could cause a generalized proinflammatory-
neurodegenerative response.  
In spite that it has been morphologically recognized for many years since Ramon y Cajal 
times, to study the biochemical signaling cascades involved in glial scar formation has been 
difficult mostly because of the in vivo nature of the process. 
In this context, we studied here the mechanisms of glial scar assembly/disassembly in 
vitro to identify potential pharmacological targets for therapeutic interventions. To achieve 
this goal we will use the classical 2-Dimensional (2D) astroglial cultures, but we will  also 
develop 3-dimensional (3D) astroglial cultures by using nanotube matrixes to attempt to 
better reproduce the in vivo situation. The results of this thesis showed that meningeal 
macrophages or ischemia-activated macrophages induce astroglial retraction and formation 
of scar-like structures in vitro. Scar-forming astrocytes over-express GFAP, S100B and TLR2-
4. Using the NF-B antagonist BAY-11-7082 we demonstrated that scar formation and its 
density is partially NF-B dependent. Finally, in 3D astroglial culture grown on hydromatrix 
nanotubes, we showed that DAMPs can induce astroglial polarization but not the formation 
of the glial scar in vitro. We conclude that TLR/ NF-B pathway is probably implicated in the 
glial scar formation or stabilization and that DAMPs and macrophages are necessary for the 
formation of glial scars in vitro. 
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AFA: Astrocyte free areas 
ATP: Adenosine triphosphate 
BBB: Blood brain barrier 
CBF: Cerebral blood flow  
CSPGs: Chondroitin sulfate proteoglycans 
DAMP: Damage-associated molecular pattern 
DMEM: Dulbecco´s Modified Eagle Medium 
ECM: Extracellular matrix 
GFAP: Glial fibrillary acidic protein  
GFP: Green fluorescent protein 
HBSS: Hank’s balanced Salt Solution 
HMGB-1: High Mobility Group Box-1 
IκB: Inhibitor kappaB 
IKK: Inhibitor kappaB kinase 
IL-1: Interleukin-1 
iNOS: Inducible nitric oxide synthase 
LPS: Lipopolysaccharide 
NF-B: Nuclear Factor kappaB 
NG2: Neural/glial antigen 2 (NG2 chondroitin sulfate proteoglycan) 
NO: Nitric oxide 
PAMP: Pathogen-associated molecular pattern 
S100B: S100 calcium-binding protein B  
TLR: Toll like receptors 
TLR2: Toll like receptor 2 
TLR4: Toll like receptor 4 
TNF-𝛼: Tumor necrosis factor alpha 
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Brain ischemia and its clinical presentation in Stroke: 
Brain remains as one of the organs we are still unable to provide a solid connection 
between the function of individual cellular players and the function of the organ itself. A 
critically important area of neuroscience research today is to understand the 
pathophysiology of stroke, one of the most common neurological diseases. Cerebrovascular 
diseases (CVDs), which account for 55% of all neurological diseases, are the leading cause of 
permanent disability, cognitive and motor disorders and dementia. 
 World Health Organization (WHO) produced a detailed report in 2008 showing the 
worldwide incidence of neurological disorders (WHO, 2008). In that report it was shown 
that only in 2005, chronic diseases accounted for 35 million (60%) of the 58 million deaths 
that occurred worldwide. Heart disease was responsible for 11.7 million of these deaths and 
stroke, the second most common cause of death, caused 5.8 million. Forty percent of stroke 
deaths occurred in people <70 years of age. More recently, it was calculated that globally, 
approximately 15 million new acute stroke events occur every year, and approximately 55 
million people have had a stroke at some point in the past. Two thirds of these individuals 
live in low- and middle-income countries. Every two seconds, someone across the globe 
suffers a symptomatic stroke (Pandian et al., 2007). The risk of cerebrovascular disease is 
disproportionately higher in low to middle income countries where, in addition, the stroke 
patients’ care is difficult to reach to these regions. During the last two decades a major 
transformation in the stroke field took place with the emergence of evidence-based 
approaches to stroke prevention, acute stroke management, and stroke recovery. The 
current challenge lies in implementing these interventions, particularly in regions with high 
incidence of stroke and limited healthcare resources, as the emerging countries.  
Well-organized stroke services and emergency transport services are lacking, many 
treatments are unaffordable, and socio- cultural factors may influence access to medical 
care for many stroke victims (Lindsay et al., 2014). By 2050, it is anticipated that 80% of 
stroke events will occur in people living in low and middle income regions. Stroke should be 
a priority on the health and basic research agenda in developing countries. The experience 
of high-income nations clearly shows that a significant improvement in the outcome of 
stroke patients can be achieved with sustained interventions. We should consider that 
Raja Sekhar Mannava                                                IMBS                                                                                8 
 
                                                                    
reaching a 2% reduction per annum in stroke mortality due to better management, would 
result in 6.4 million fewer deaths from stroke (Pandian et al., 2007). 
Unfortunately there are only a few options to treat stroke patients. The immediate 
goal of acute ischemic stroke therapy is to save the ischemic penumbra through 
recanalization of the occluded cerebral blood vessel. This is currently attempted through 
thrombolytics, which are pharmacological agents that can break up a clot blocking the blood 
flow. To date, the only approved thrombolytic for treatment of acute ischemic stroke is the 
recombinant tissue plasminogen activator (Alteplase, r-tPA). However, r-tPA has 
enormous limitations due to small time window and high costs, as well as concerns 
regarding adverse bleeding risk due to the hemorrhagic conversion of the stroke (Balami et 
al., 2013). Other than thrombolytic drugs, there are not yet good treatments that minimize 
brain tissue loss and dysfunction after stroke. Over 1000 drug trials for stroke have now 
failed (O’Collins et al., 2006). In most of these trials, neurons were exclusively targeted, for 
instance using drugs that blocked neuronal glutamate receptors (Appendix 1). Yet the extent 
to which glial are killed in stroke and the consequences of this cell loss for the surrounding 
neuronal networks has received relatively little attention. Also there is a crucial need to 
more fundamentally understand why the Central Nervous System (CNS) is so much more 
vulnerable to ischemia than non-CNS tissues. 
Excitotoxicity is certainly a central element of ischemic damage that is unique to the 
CNS and it was the main reason that aimed the basic and clinical research on strategies to 
antagonize the glutamate excitotoxicity after stroke during the last 20 years. However, the 
massive failure of these strategies in the clinical field (see appendix 1) makes necessary to 
deeply re-analyze the mechanisms underlying this differential sensitivity of CNS to ischemia. 
Going to the most straightforward hypothesis, it could be considered that neurons have 
exactly the same intrinsic vulnerability to ischemia as any other cell type and that the 
greater brain vulnerability to ischemia might simply rely on the lower redundancy and repair 
ability of the brain compared with liver or kidney. Although it is simple, this hypothesis does 
not consider the complexity of brain networks, the task division and crosstalk among 
different CNS cell types that allows brain function and information processing. The 
neurovascular unit hypothesis presented in 2006 by Del Zoppo (Del Zoppo, 2006) has been a 
main addition to understand brain response to ischemia. Neurovascular unit consists of 
Raja Sekhar Mannava                                                IMBS                                                                                9 
 
                                                                    
microvessels (endothelial cells-basal lamina matrix-astrocyte end-feet and pericytes), 
astrocytes, neurons and their axons, and other supporting cells (e.g., microglia and 
oligodendroglia) that present different functions but also show a clear division of metabolic 
activities and functional crosstalk (Figure 1). This unit provides a framework for bi-
directional communication between neurons and their supply microvessels with the 
participation of the intervening astrocytes. The neurovascular unit accounts both for cellular 
intercommunication and nutrient perfusion at the same time (Del Zoppo et al., 2006). 
Virtually every aspect of brain development and function involves a neuron-glial 
partnership; therefore the answer to every important question about brain disease will also 
involve glia. In the context of the neurovascular unit, a better strategy would be to 
understand how glial pathology contributes to neuronal dysfunction and vice versa (Lobsiger 
and Cleveland, 2007). 
 
  
Figure 1. The neurovascular unit. A simplified depiction of the relationship between neuron and 
axon location and a supply microvessel. The astrocyte end-feet form the abluminal portion of 
capillaries and small microvessels via their attachment to the basal lamina matrix, and astrocyte 
arborizations contact neurons (Del Zoppo et al., 2010). 
 
Ischemic core and penumbra: 
The concept of the ischemic penumbra was initially proposed by Astrup in 1981 and 
represented an important milestone for understanding the temporal and spatial evolution 
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of focal ischemic brain injury. Acute stroke causes an irreversibly damaged ischemic core 
and a potentially salvageable surrounding tissue named penumbra, a reversibly injured 
brain tissue around ischemic core; which is the pharmacological target for acute ischemic 
stroke treatment (Astrup et al. 1981). 
The penumbra concept suggests that different areas within the ischemic region 
evolve into irreversible brain injury over time and that this evolution is most critically linked 
to the severity of decline in cerebral blood flow (CBF). The ischemic penumbra was initially 
defined as a region of reduced CBF with absent spontaneous or induced electrical potentials 
that still maintained ionic homeostasis and transmembrane electrical potentials. This 
narrow definition has evolved, and 2 subsequent definitions should be focused upon. 
Hossmann (1999) characterized the ischemic penumbra as “a region of constrained blood 
supply in which energy metabolism is preserved”. Ginsberg and Pulsinelli (1994), proposed 
that energy metabolism might be intermittently compromised within the ischemic 
penumbra. If the ischemic penumbra is characterized by these approaches, then a reduction 
of CBF to levels between a lower threshold of 10–15 mL/100 g/min and an upper threshold 
of approximately 25 mL/100 g/min is likely to identify penumbral tissue. The ischemic core 
of infracted tissue has a CBF value below the lower threshold. The upper threshold for CBF 
decline approximates that level associated with the development of neurologic deficits and 
is substantially less severe than the CBF decline associated with loss of electrical activity, as 
proposed by the original ischemic penumbra concept. The penumbra had a CBF rate below 
normal, but it was higher than the focal zone (Ischemic core). This reduced CBF caused 
cessation of electrical signals but not loss of ion homeostasis. Thus, the penumbral cells are 
still viable but their metabolism is reduced because the CBF was lower than normal (25% to 
50%), exhibiting acidosis, edema and decreased protein synthesis. It is argued that electric 
failure and membrane failure occurred at different CBF, and that this was the underlying 
reason for the two zones (Figure 2). 
It was also argued that the necrosis that characterizes the ischemic core slowly 
invades the area of the penumbra, recruiting more and more cells that will eventually die by 
apoptosis due to delayed neuronal death. Any potential intervention in focal ischemic stroke 
would have to focus on preventing the spread of the necrotic zone into the penumbra, since 
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these are the cells at risk after a stroke. Hence, the important goal in stroke treatment is to 
save the penumbra as much and as early as possible. 
 
Figure 2. Correlation between energy thresholds and blood flow thresholds. The form and pathway 
of cell death closely are closely associated with energy state levels. Blood flow reduction causes 
specific metabolic disturbances at certain blood flow thresholds. The ischemic core has depleted ATP 
level whilst the penumbra has gradient reduction of ATP level between normal tissue and ischemic 
core (Liu et al., 2010). 
 
Glial cells in the CNS: 
Oligodendrocytes:  
Oligodendrocytes are the myelinating glia in the CNS and wrap their membranes 
around axons to form myelin. In addition to providing insulation and trophic support to 
neuronal axons, oligodendrocytes  are active participants in nervous system function, 
sculpting the structural and electrical properties of axons by controlling their diameter, as 
well as the spacing and clustering of ion channels at nodes and paranodes. The molecular 
mechanisms that enable oligodendrocytes to recognize, ensheath, and wrap axons are not 
completely understood (Chan et al., 2004). Oligodendrocytes are also lost in brain trauma 
and spinal cord injury either directly or as an indirect result of axon injury, degeneration and 
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inflammation. Axonal signals, not yet identified, are required for the differentiation of 
Oligodendrocyte Precursor cells (OPCs) into oligodendrocytes and for the survival of 
oligodendrocytes (Ben Barres 2008). More recently it has been shown that oligodendrocytes 
crosstalk not only with the axons that wrap with myelin, but also interact with microglia and 
astrocytes (Peferoen et al., 2014). 
 
Microglia:  
Microglia are the professional immune system cells that are resident in the CNS and 
constitute about 10% of CNS glia (Hanisch and Kettenmann, 2007; Soulet and Rivest, 2008). 
Normally blood-derived macrophages are situated in the perivascular space, whereas 
microglia is located within the brain parenchyma. Like perivascular macrophages of the 
brain, microglia is derived from uncommitted myeloid progenitor cells but they invade the 
brain neonatally (Santambrogio et al., 2001). Although microglia displays at least some 
phagocytic ability, they do not appear to have the strong professional phagocytic ability 
exhibited by activated macrophages (Ben Barres 2008). In addition to affecting synaptic 
activity, microglia plays an important role during CNS development in mediating the 
selective elimination of inappropriate synaptic connections during the formation of mature 
neural circuits. 
Microglia express Toll-Like Receptors (TLR) and NOD-like receptors (NLR), allowing 
them to detect Pathogen-Associated Molecular Patterns (PAMPs) and the molecular 
signatures of injury named Damage-Associated Molecular Patterns (DAMPs). The 
PAMP/DAMP-TLR interaction usually leads to the transcription of NF-B dependent 
proinflammatory cytokine genes. Local (Suzuki et al., 2011) and systemic (Püntener et al., 
2012) infections, neurodegenerative conditions (Browne et al., 2013), and sterile injury 
(Wang 2010) have been reported to activate microglia. Once activated, microglia retracts 
their ramifications and acquires an amoeboid morphology, becoming indistinguishable from 
activated macrophages. Resident microglia and peripheral macrophages play pivotal roles in 
the post-ischemic inflammation. As both cell types derive from primitive myeloid cells, they 
express many shared markers (CD11b, F4/80, Iba-1) (Ginhoux et al., 2010), complicating the 
study of microglial activity by immunohistochemistry. Like macrophages, microglia can have 
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either an M1, classically activated phenotype, “classically activated via toll-like receptors or 
interferon-γ”, or an M2, alternatively activated phenotype, “alternatively activated by 
interleukin 4 or interleukin 13” (Perry et al., 2010)(Figure 3). M1 microglia are considered to 
be proinflammatory and secrete TNF-𝛼, iNOS, and CCL2. They express CD80, CD86, and 
MHCII on their cell surface, possessing the capability to present antigens to T cells 
(Starossom et al., 2012). They express IL-23, giving implications that microglia T-cell 
crosstalk may occur. Microglia also produces IL-1𝛽 and IL-18 through activation of the 
inflammasome (Ransohoff and Brown 2012). 
M2 microglia are interpreted to be healing cells that have a role in  neuroprotection 
and repair after injury showing arginase activity and upregulation of neurotrophic factors 
(Kawanokuchi et al., 2008)(Figure 3). Because of this M1 or M2 polarization, microglia has 
the potential to contribute to the inflammatory secondary injury or to facilitate 
neuroprotection in CNS disease and injury. Microglia also shows an extensive crosstalk with 
astrocytes. 
Astrocytes release signals such as CSF-1 and ATP that can signal to microglia, 
whereas microglia release signals such as TNF-𝛼 that can signal to astrocytes and modulate 
their response to injury. Microgliosis and reactive astrocytosis generally occur together, but 
it is not clear whether there is a causal connection and, if so, in which direction. Nor is there 
agreement on whether lessening either type of gliosis will be helpful or harmful for neuronal 
survival after CNS injury (Ben Barres 2008). 
 
Figure 3. Microglia polarization is characterised by distinct phenotypes (Nakagawa Y, Chiba K 2014). 
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Astrocytes:  
Astrocytes constitute nearly half of the cells in the human brain. Classical functions 
of astrocytes giving physical and metabolic support to neurons were described several 
decades ago, but more recent findings have unveiled a plethora of astroglial functions in 
healthy and injured CNS (Figure 4). Astrocytes fall into at least two main classes 
distinguished by morphology, antigenic phenotype, and location. Accordingly, it is 
speculated that they most likely differ in some of their main functions; however these 
differences are far from being demonstrated in vivo. Protoplasmic astrocytes are found 
throughout all gray matter and exhibit morphology of several stem branches that give rise 
to many finely branching processes in a uniform globoid distribution. On the other hand, 
fibrous astrocytes are found throughout all white matter and exhibit a classical morphology 
with many long fiber-like processes intermingled among myelinated axons (Ramon y Cajal 
1909). 
In gray matter, a single astrocyte extends thousands of fine membranous processes 
that ensheath synapses and microvasculature (Araque et al., 1999; Ventura and Harris, 
1999; Bushong et al., 2002). Beyond their protoplasmic or fibrous morphologically defined 
phenotypes, gene profiles indicate a surprising amount of regional astrocyte heterogeneity 
that has been underestimated (Zhang and Barres, 2010). 
Astrocytes have a main role in neuronal development, and thus it is a common view 
in the field that those mechanisms are re-called during the regenerative processes occurring 
in the long term after focal CNS injury. During CNS development, molecular boundaries 
formed by astrocytes take part in guiding the migration of developing axons and certain 
neuroblasts (Powell and Gelle 1999). In latter steps, astrocytes are essential for the 
formation and functional activation of developing synapses by releasing molecular signals 
such as thrombospondin (Ben Barres, 2008, Christopherson et al., 2005, Ullian et al., 2001). 
Astrocytes secrete a protein, not yet identified, that induces postsynaptic glutamate (AMPA) 
responsiveness of neurons (Christopherson et al., 2005). Astrocytes appear also to influence 
developmental synaptic pruning by releasing signals that induce expression of complement 
C1q in synapses and thereby tag them for elimination by microglia (Ben Barres 2008, 
Stevens et al., 2007). Interestingly, several evolutionarily conserved phagocytic pathways 
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were found to be highly enriched in astrocytes including the Draper/Megf10 and 
Mertk/integrin alpha (v) beta5 pathways, suggesting that mammalian astrocytes have the 
potential of being professional phagocytes, which leads to an interesting possibility that 
astrocytes are actively mediating synapse elimination by phagocytosis using these pathways 
during development, normal adulthood, or after injury (Chung et al., 2013). 
 
Figure 4. Astrocyte functions in healthy CNS (Sofroniew and Vinters, 2010) 
 
The blood brain barrier (BBB) is a diffusion barrier that impedes the influx into brain 
parenchyma of certain molecules on the basis of polarity and size (Abbott et al., 2006, 
Ballabh et al., 2004). The principal cellular constituents of the BBB are cerebral capillary 
endothelial cells that form tight junctions and are surrounded by a basal lamina, 
perivascular pericytes, and astrocyte endfeet. Studies suggest a role for astrocytes in 
regulating BBB properties of cerebral endothelial in vivo in adult mice through specific 
signaling mechanisms on astrocyte endfeet that when disrupted cause BBB leaks (Araya et 
al., 2008). 
Astrocytes make extensive contacts and have multiple bidirectional interactions with 
blood vessels, including regulation of local CNS blood flow. Recent findings show that 
astrocytes produce and release various molecular mediators, such prostaglandins (PGE), 
nitric oxide (NO), and arachidonic acid (AA), that can increase or decrease CNS blood vessel 
diameter and blood flow in a coordinated manner based on the neuronal  activity and local 
environmental conditions (Gordon et al., 2007; Iadecola and Nedergaard, 2007; Koehler RC 
et al., 2009). 
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Astrocyte processes are rich in the aquaporin 4 (AQP4) water channel and in 
transporters for the uptake of K+ (Seifert et al., 2006, Simard et al., 2004, Zador et al., 2009). 
AQP4 water channels are densely clustered along astrocyte processes that contact blood 
vessels and play a critical role in regulating fluid homeostasis in healthy CNS and play roles 
in both vasogenic and cytotoxic edema. Astrocyte processes envelop essentially all synapses 
(Brown and Ransom 2007; Peters et al., 1991) and exert essential functions in maintaining 
the fluid, ion, pH, and transmitter homeostasis of the synaptic interstitial fluid in a manner 
that is critical for healthy synaptic transmission. However, these astrocytic end-feet 
surrounding microvasculature are also responsible for a further reduction in blood perfusion 
in areas surrounding ischemic core when cell swelling and cytotoxic edema occurs 
(Nedergaard and Dirnagl, 2005). 
Beyond their role in the synaptic maturation, stabilization and pruning commented 
above, astrocyte processes at synapses also play essential roles in transmitter homeostasis 
by expressing high levels of transporters for neurotransmitters such as glutamate, GABA, 
and glycine that serve to clear the neurotransmitters from the synaptic space (Figure 4) 
(Sattler et al., 2006). 
Bidirectional communication occurs between neurons and astrocytes. This means 
that synapses do not consist of just pre- and postsynaptic neuronal elements, but also have 
an astrocytic projection that envelops the synapse. This close spatial relationship has led to 
the hypothesis of the tripartite synapse, to acknowledge the astrocytes contribution (Figure 
5). The synaptic localization of astrocytes means they are ideally placed to monitor and 
respond to synaptic activity. Astrocytes play direct roles in synaptic transmission through 
the regulated release of synaptically active molecules including glutamate, purines (i.e. ATP 
and adenosine), GABA, and D-serine (Halassa MM et al., 2007, Nedergaard Met al., 2003, 
Perea G et al., 2009, Shigetomi E et al., 2008). The release of such gliotransmitters occurs in 
response to changes in neuronal synaptic activity, involves astrocyte excitability as reflected 
by increases in astrocyte intracellular calcium , and can alter neuronal excitability (Halassa et 
al., 2007, Nedergaard et al., 2003, Perea et al., 2009, Shigetomi et al., 2008). In spite of 
being a prevalent view during the last 15 years, the concept of a regulated, vesicular release 
of gliotransmitters has been recently seriously questioned. Fujita and colleagues (2014) 
demonstrated that the transgenic mice expressing dnSNARE in astrocytes used to 
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demonstrate the in vivo role of the vesicular release of gliotransmitters present leaky 
neuronal transgene expression that could led to a misinterpretation of the results (Fujita et 
al., 2014; Sloan and Barres, 2014). 
Astrocytes have the potential to exert long-term influences on synaptic function 
through the release of growth factors and related molecules. Astrocytes are also sources of 
neuroactive steroids (neurosteroids), including estradiol, progesterone and various 
intermediaries and metabolites that can have synaptic effects, particularly at GABA 
receptors (Garcia-Segura and Melcangi, 2006). 
Astrocytes, which have processes that on the one hand contact blood vessels and on 
the other hand contact neuronal perikarya, axons (at nodes of Ranvier), and synapses, are 
well positioned to take up glucose from blood vessels and furnish energy metabolites to 
different neural elements in gray and white matter (Figure 4). Astrocytes are the principal 
storage sites of glycogen granules in the CNS and the greatest accumulation of astrocytic 
glycogen occurs in areas of high synaptic density (Peters et al., 1991, Phelps 1972). 
Compelling evidence now demonstrates that astrocytic glycogen utilization can sustain 
neuronal activity during hypoglycemia and during periods of high neuronal activity (Brown 
and Ransom 2007, Suh et al., 2007).  
 
 
Figure 5. A tripartite synapse. Astrocytes 
express many of the same receptors as 
neurons. When neurotransmitters are 
released from the presynaptic terminal of 
a neuron, astrocytic receptors are thought 
to be activated, leading to a rise in calcium 
ions in the astrocyte and the release of 
various active substances, such as ATP, 
which act back on neurons to either 
inhibit or enhance neuronal activity. 
However this evidence obtained in vitro 
remains to be clarified in vivo (Sloan and 
Barres, 2014) Astrocytes also release 
proteins, which control synapse 
formation, regulate presynaptic function 
and modulate the response of the 
postsynaptic neuron to neurotransmitters 
(Allen and Barres, 2009). 
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Reactive Gliosis and glial scar formation is a generic response to brain injury: 
Astrocytes respond to all forms of insults by a generic process commonly referred to 
as reactive astrogliosis. Reactive astrogliosis is not simply an all-or-none phenomenon, but 
rather a constitutive, graded, multi-stage, and evolutionary conserved defensive astroglial 
reaction ranging from subtle alterations in gene expression to scar formation (Sofroniew, 
2009). Although the increasing severity of reactive astrogliosis transition seamlessly along a 
continuum, it is convenient for purposes of description and classification to recognize three 
broad categories as originally proposed by Sofroniew in 2009: 
Mild to moderate reactive astrogliosis. In mild or moderate reactive astrogliosis there is 
variable up regulation of genes, as well as hypertrophy of cell body and processes that 
occurs within the domains of individual astrocytes (Wilhelmsson et al., 2006) without 
substantive intermingling or overlap of processes of neighbouring astrocytes or loss of 
individual domains, and with increased GFAP expression (Figure 6b). Because there is little 
reorganization of tissue architecture, if the triggering injury is resolved, then mild or 
moderate reactive astrogliosis exhibits the potential for resolution in which the astrocytes 
return to an appearance similar to that in healthy tissue (Sofroniew 2009). 
Severe diffuse reactive astrogliosis. In severe diffuse reactive astrogliosis there is 
pronounced up regulation of expression of GFAP and other genes, together with 
hypertrophy of cell body and processes, as well as astrocyte proliferation, resulting in 
considerable extension of processes beyond the previous domains of individual astrocytes. 
As a result, there is substantive intermingling and overlapping of neighbouring astrocyte 
processes with disruption of individual astrocyte domains (Figure 6c). These changes can 
result in long-lasting reorganization of tissue architecture that can extend diffusely over 
substantive areas. Severe diffuse reactive astrogliosis is generally found in areas 
surrounding severe focal lesions, infections or areas responding to chronic 
neurodegenerative injury. 
Severe reactive astrogliosis with compact glial scar formation. Severe reactive astrogliosis 
with compact glial scar formation includes pronounced up regulation of GFAP and other 
genes, and pronounced hypertrophy of cell bodies and processes. In addition, groups of 
reactive astrocytes exhibit overlapping of reactive astrocyte processes, loss of individual 
Raja Sekhar Mannava                                                IMBS                                                                                19 
 
                                                                    
astrocyte domains, evidence of substantive astrocyte proliferation, and the clear formation 
of dense, narrow, and compact glial scars (Figure 6d). Recent experimental evidence 
indicates that these astrocyte scars act as neuroprotective barriers to inflammatory cells, 
and that they form in particular along borders to severe tissue damage necrosis, infection or 
autoimmune-triggered inflammatory infiltration (Wanner et al., 2013). An important feature 
of these glial scars is the deposition of a dense chondroitin sulphate proteoglycans (CSPG) 
extracellular matrix that inhibits axonal growth. Triggering insults include penetrating 
trauma, severe contusive trauma, invasive infections or abscess formation, neoplasm, 
chronic neurodegeneration or systemically triggered inflammatory challenges. Glial scar 
formation is associated with substantive tissue reorganization and structural changes that 
are long lasting and persist long after the triggering insult may have resolved. 
  
Figure 6. Schematic representations that 
summarize different levels of reactive 
astrogliosis. a) Astrocytes in healthy CNS 
tissue. b) Mild to moderate reactive 
astrogliosis comprises variable changes in 
molecular expression and functional 
activity together with variable degrees of 
cellular hypertrophy. c) Severe diffuse 
reactive astrogliosis includes changes in 
molecular expression, functional activity 
and cellular hypertrophy, as well newly 
proliferated astrocytes (with red nuclei in 
figure). d) Severe reactive astrogliosis 
with compact glial scar formation occurs 
along borders to areas of overt tissue 
damage and inflammation, and includes 
newly proliferated astrocytes (with red 
nuclei in figure) and other cell types (gray 
in figure) such as fibromeningeal cells, 
blood derived macrophages, NG2 OPCs, 
as well as deposition of dense 
extracellular matrix. In the compact glial 
scar, astrocytes have densely overlapping 
processes (from Sofroniew and Vinters, 
2010).  
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Reactive astrogliosis and glial scar formation play essential roles in regulating CNS 
inflammation. In response to different kinds of stimulation, reactive astrocytes express and  
secrete  different  molecules with either pro- or anti-inflammatory potential (Eddleston et 
al., 1993, John et al., 2003), and reactive astrocytes can exert both pro- and anti-
inflammatory effects on microglia/macrophages (Farinas et al., 2007, Min et al., 2006). A 
large body of experimental studies indicates both pro- and anti-inflammatory regulatory 
functions in vivo are regulated by specific molecular signalling in a context-dependent 
manner that is pathways (Burda and Sofroniew 2014). Reactive astrocytes exert different 
activities at different times after insults, or in different geographical locations in relation to 
lesions, as determined by context-specific signalling mechanisms. For example, reactive 
astrocytes may exert pro-inflammatory roles at early times after insults and in the centre or 
immediate vicinity of lesions, but exert anti-inflammatory roles at later times and at the 
borders between lesions and healthy tissue. 
Apart from the hallmark features of hypertrophy of astrocyte cellular processes and 
upregulation of intermediate filament proteins, in particular the upregulation of glial 
fibrillary acidic protein (GFAP), reactive astrogliosis and glial scar formation are also 
accompanied with increased production of CSPGs, inducible NO synthase (iNOS), and 
calcium-binding protein S100B, etc. (Table 1). These factors are considered as the functional 
markers of astrocyte reactivity whose levels are upregulated following CNS injuries 
(Sofroniew 2009, Escartin et al., 2008, Kang et al., 2011, Eddleston et al., 1993). 
Many different types of intercellular signalling molecules are able to trigger reactive 
astrogliosis, including: i) Large polypeptide growth factors and cytokines such as IL6, LIF, 
CNTF, TNF-α, INFc, TGF-β, FGF2, etc. secreted by glia or blood derived macrophages; ii) 
Mediators of innate immunity such as PAMPs and DAMPS by activating Pattern Recognition 
Receptors like RAGE and TLR (Villarreal et al., 2014); iii) Neurotransmitters such as 
glutamate and noradrenalin; iv) Purines such as ATP; v) Reactive oxygen species (ROS) 
including nitric oxide (NO); vi) Hypoxia and glucose deprivation; vii) Products associated with 
neurodegeneration such as β –amyloid or with  systemic metabolic toxicity such as NH4+ 
(reviewed in Sofroniew, 2009; Burda and Sofroniew  2014). 
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Evidence suggests that pro-inflammatory cytokines such as TNF-α, IL-1β and IL-6 may 
act as the initial triggers of reactive astrocytes in the acute phase of spinal cord injury 
(Kordek et al., 1996, Lin et al 2006). However, accumulating evidence is showing that DAMP 
gradient originated by focal CNS lesions can be sufficient to induce a graded reactive gliosis 
as seen in vivo (Villarreal et al., 2014; Burda and Sofroniew, 2014). At later stages, other 
mediators including autocrine molecules like S100B are able to maintain astrocytes 
reactivity (Vitellaro-Zuccarello et al 2008, Buffo et al., 2010; Villarreal et al., 2014). 
Interestingly, reactive astrocytes can release the majority of these triggering molecules 
themselves, which in turn activate more distal astrocytes, microglia and other cell types. It is 
not completely understood how activated microglia and leukocytes play a modulatory role 
in astrogliosis and it remains to be elucidated the complex crosstalk among these cell types 
after focal CNS injury. 
STAT3 signalling has been implicated as a key mediator of astrocytic scar formation 
after SCI (Herrmann et al., 2008, Okada et al 2006). STAT3 conditional knockout mice failed 
to form a typical glial scar after SCI and that led to a widespread lesion and poor recovery of 
function. Lack of STAT3 activation particularly resulted in the inability of astrocytes to 
migrate to the lesion site and contain the injured area. This resulted in exacerbated influx of 
inflammatory cells at the site of SCI (Herrmann et al., 2008, Okada S et al 2006; Wanner et 
al., 2013). This evidence emphasized the impact of STAT3 activation in astrocytes and the 
importance of reactive astrogliosis and glial scar formation in restraining leukocyte 
infiltration and reducing the initial tissue damage after SCI. Role of NF-B in glial scar 
formation has not been studied, but there are several studies showing the activation of NF-
κB pathway in astrocytes following SCI (Wanner et al., 2013), brain ischemia (Villarreal et al., 
2011, 2014), sleep apnea (Aviles Reyes et al., 2010). Moreover, blockage of the NF-B 
pathway or upstream RAGE pattern recognition receptor showed to reduce reactive gliosis 
in vivo in a model of sleep apnea (Angelo et al., 2014). 
Like RAGE, TLR are also pattern recognition receptors that are critical components of 
the innate immune system activated after ischemic injury in the CNS. TLR activation induce 
the nuclear translocation of the transcription factor nuclear factor-kappa B (NF-B), leading 
to the subsequent expression of several proinflammatory genes (reviewed in Hanke and 
Kielian, 2011). 
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Nuclear transcription factor-B (NF-B), which can be activated by stimuli associated 
with damage and in turn can promote expression of pro-inflammatory cytokines, is thought 
to play a central role in most inflammatory responses. When the CNS is damaged, the 
resident cell types that activate NF-B mount a response have not been fully defined, but 






















Table 1. Different functional categories of genes and molecules modulated by reactive astrocytes 
in vivo or in vitro. ↑↓ arrows indicate upregulation or downregulation. Note that some families of 
molecules (e.g. cytokines) simultaneously can have some members that are ↑ regulated and some 
that are ↓ regulated. In addition, some individual molecules (e.g. glutathione) can be either ↑ or ↓ 
regulated by different triggers of astrogliosis or at different times after insults (Sofroniew MV 2009). 
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Functional categories Molecular changes in reactive astrocytes 




NF-B ↑; STAT3 ↑; cAMP ↑; Olig2 ↑; mTor ↑; 
SOX9 ↑; etc. 
 
Extracellular matrix and cell–cell 
interactions 
Chondroitin sulfate proteoglycans ↑↓; 
collagens ↑↓; laminins ↑; integrins ↑; 
  Cadherins ↑↓; ephrins ↑; metalloproteases ↑  
Inflammatory cell regulators 
 
Cytokines and growth factors ↑↓;  
glutathione↑↓   
Fluid and ion homeostasis 
 
AQP4 ↑↓; Na/K transporters ↑↓  
Extracellular transmitter clearance 
 
Glutamate transporter ↑↓   
Vascular regulators 
 
PGE ↑↓; NO ↑↓  
Purines and receptors 
 
ATP ↑↓; P2Y ↑↓ 
Oxidative stress and protection 
 
NO ↑↓; NOS ↑; SOD↑↓ ;  
glutathion ↑↓ 
Gap junction proteins 
 




Synapse formation and remodeling 
 
Thrombospondin ↑↓; complement C1q ↑↓  
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Increasing evidence shows glial scar as a highly complex system of interacting cell 
types where, dynamic polarization of different populations of cells at distinct times after 
injury orchestrates the formation of a structurally layered scar. Reactive astrocytes, 
activated microglia/macrophages, NG2+ oligodendrocyte progenitors and PDGFβ expressing 
fibroblasts/stromal cells are the major cell types (Figure 7). Breakdown of the blood–brain 
barrier (BBB) and leakage of blood and serum elements into the CNS parenchyma is 
considered a key event in glial scar formation. In agreement with this scenario, several 
molecules derived from the blood or produced via inflammation have been envisioned as 
potential triggers of scar formation. Perhaps equally as important, leukocyte extravasation 
and accumulation of inflammatory cells in the lesion core have a main role in the positioning 
of the glial scar (Figure 7). Recent work using 3D-imaging combined with genetic labeling of 
microglia and infiltrating monocyte derived macrophages (CX3CR1-GFP) has revealed that 
the density of inflammatory cells increases by many folds in the lesion core (Ertürk et al., 
2011). Indeed, activated macrophages/microglia markedly increase expression of matrix 
metalloproteases (MMPs) after injury, and this contributes to vascular permeability and 
accumulation of more inflammatory cells within the lesion. While these pools of activated 
macrophages/microglia are thought to be important for lesion debridement, they also drive 
secondary injury through inflammatory processes that facilitate reactive astroglia 
conversion into the proinflammatory-neurodegenerative phenotype (Zamanian et al., 2012). 
Penetrating injuries that disrupt the meninges are associated with meningeal 
fibroblast infiltration in the lesion core. However, in a recent study, Soderblom et al. (2013) 
used genetic fate mapping to show that collagen-1α1/PDGFRβ/CD13 positive perivascular 
fibroblasts proliferate even in response to contusive injury where the meninges are largely 
intact, and form a major cellular component of the fibrotic scar. The fibrotic core of the glial 
scar appears in its mature form by 2 weeks post-injury (Göritz et al., 2011; Soderblom et al., 
2013). Adding to the considerable complexity of the lesion environment the core 
surrounded by the scar also show  several different cell types that undergo migration and 
proliferation when their usual niche is disturbed due to trauma. For example, injury disrupts 
progenitor niches. After damage, a large and heterogeneous population of immature cells 
expressing markers associated with progenitors (including nestin, vimentin, and NG2) invade 
the lesion core (Busch et al., 2010; Lytle et al., 2006; Zai and Wrathall, 2005). In vivo imaging 
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has demonstrated that NG2 oligodendrocyte progenitors rapidly extend processes and 
migrate toward CNS lesions in a role that seems not to be directly connected with the 
generation of new myelinating oligodendrocytes (Hughes et al., 2013). This migration is 
preceded by microglia temporally, and it is thought that dynamic polarization of different 
populations of cells at distinct times after injury orchestrates the formation of a structurally 
layered scar (Hughes et al., 2013). Ultimately the glial scar serves as a vital structure that 
preserves intact circuit elements from damage by intense inflammation at the lesion core. 
 
Figure 7. Anatomy of a contusive spinal cord lesion to show the cellular components of the core 
and surrounding scar. As in brain ischemia, spinal cord lesions have two distinct components—the 
lesion penumbra composed of hypertrophic astrocytes, and the lesion core composed of NG2+ 
oligodendrocyte precursor cells, PDGFRβ+ fibroblasts, and macrophages/microglia. Note the layered 
architecture of the glial scar (Cregg et al., 2014).   
 
Glial Scar formation as physiological and bio-molecular barrier for axonal regrowth: 
Most of the studies on glial scar formation, its advantages, and its effects on 
regeneration failure are studies performed in spinal cord injury models due to its 
importance for the functional recovery failure in humans. Axons attempting to cross the 
glial scars are trapped and become dystrophic in a process that was described by Ramon y 
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Cajal almost a century ago (Ramón y Cajal, 1928), but still today not completely understood. 
Phenotypical transformation of scar-forming astrocytes includes a dramatic change in the 
star-like unpolarized morphology towards a polarized phenotype that presents an 
intermingled network of astroglial processes around the lesion. In addition, some reports 
evidenced a rapid migration of astrocytes away from the inflammatory epicentre that is 
speculated to collaborate in the initiation of the astrocytic scar at the lesion penumbra 
(Cregg et al., 2014). After forming the mesh-like layer of entangled filamentous processes, 
scar-forming astrocytes begin synthesizing and depositing chondroitin sulphate 
proteoglycans (CSPGs) into the extracellular matrix within 24h after injury. High 
concentrations of CSPGs persist throughout the lesion for months, which acts as a physical 
and molecular barrier that entraps dystrophic axons and severely limits their ability to 
regenerate (Davies et al., 1997).  
Dystrophic growth cones were first described as “sterile clubs” by Ramón y Cajal, 
who also noted their persistence in a stable and quiescent state (Ramón y Cajal, 1928). For 
many years, these unusually shaped end bulbs were considered to be sterile, and therefore 
incapable of extending a growth cone. More recent research has indicated that axons with 
dystrophic endings do not lose their ability to regenerate, and that they can in fact return to 
active growth states (Houle et al., 2006; Kwon et al., 2002; Li and Raisman, 1995). Live 
imaging of growth cones that stall and become dystrophic in a gradient of CSPGs has 
revealed that—despite their abnormal appearance and lack of forward movement—
dystrophic endings can be extremely dynamic at least for a few days in vitro (Tom et al., 
2004). Disorganized microtubules underlie the formation of the dystrophic growth cone 
(Ertürk et al., 2007). 
After injury a large population of fibroblasts takes up residence in the lesion core, 
forming a fibrotic scar replete with extracellular fibronectin, collagen, and laminin (Shearer 
and Fawcett, 2001). Within the lesion, meningeal fibroblasts have an active role segregating 
from astrocytes via Ephrin-B2/EphB2 bidirectional signaling (Bundeson et al., 2003), and are 
thought to contribute to the inhibitory properties of the scar by expression of repulsive axon 
guidance molecules (Pasterkamp et al., 1999) and also by promoting astrocytic reactivity 
(Wanner et al., 2008). 
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At least a subset of invading progenitors, NG2-OPC glia, seems to act as a highly 
attractive substrate for dystrophic axons, helping to stabilize them within the hostile lesion 
environment (Busch et al., 2010; McTigue et al., 2006). It is not completely understood how 
NG2 cells interact with entrapped axons and which is the final effect for the constrain of 
axonal growth (Bergles et al., 2000; Chittajallu et al., 2004; Lin et al., 2005). 
More recent experiments with in vivo imaging of bone marrow chimeric animals 
have led to the surprising finding that activated macrophages, and not microglia, are 
responsible for prolonged dieback of injured axons after injury (Horn et al., 2008). In vitro 
experiments indicate that macrophages initiate dieback through matrix metalloprotease 
activity and direct physical interaction with injured axons (Horn et al., 2008). 
Having in mind the enormous importance of the axonal growth inhibition by 
components of the glial scar for the human health, the study of glial scar formation and the 
strategies for overcoming axonal growth collapse in glial scars are a main objective of 
modern neuroscience.  
 
Technical and physiological problems to study glial scar formation: 
One of the main reasons for the lack of complete understanding about the pathways 
involved in the glial scar formation and subsequent axonal failure to regrowth is the in vivo 
nature of the phenomenon. Traumatic brain injury, brain ischemia and spinal cord injury 
share the main sequential steps in the development of the lesion. Indeed, these three 
different pathological states share the core/penumbra distribution and the glial scar 
formation that prevents axons from regrowing. 
The traditional in vitro 2-dimensional culture has been used to study many features 
of reactive gliosis and glial scar formation. However, these systems suffer from number of 
limitations, such as prominent signs of cellular stress, undesired baseline activation, or the 
loss of many in vivo morphological and physiological features of astrocytes. On the other 
hand, cells cultured in 3D matrixes exhibit features that are closer to the complex in vivo 
conditions (Vinci et al., 2012). The 3D culture models have proven to be more realistic for 
translating the study findings for in vivo applications. One important contribution for the 
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“closer-to-in vivo” behavior of cells when grown as 3D cultures is the matrices and scaffolds 
that are used for obtaining such cultures. The CNS is a very unique tissue, as compared to 
other organs in the body, as it has very unusual extracellular matrix (ECM) structures, as 
well as many other unique characteristics, including its soft physical properties. Natural 
brain tissue, which has an elastic modulus of around 500 Pa, is very soft compared to other 
tissues, such as muscle, which possesses an elastic modulus of around 104 Pa (Leipzig et al., 
2009). These differences in mechanical properties, structure, and composition of ECM have 
a profound effect on cell function. Whereas cells in most other organs bear loads, and 
therefore experience mechanical stimuli, cells in the CNS do not. Another major difference 
is the composition of the ECM of the CNS. Many ECM components, such as fibronectin and 
collagen, which are plentiful in other organs, are virtually absent in the CNS, whereas there 
is an abundance of different types of proteoglycans, localized to intercellular spaces 
between neurons and glial cells (Bandtlow  et al., 2000). 
Many different types of hydrogel systems have been evaluated for CNS applications 
in order to attempt to mimic the biochemical and mechanical properties of the CNS. These 
include both naturally derived hydrogels, including collagen, hyaluronic acid (HA), agarose, 
alginate, chitosan, methyl cellulose (MC), xyloglucan, Matrigel, fibrin, PolySia-based 
hydrogels, peptide hydrogels, as well as synthetic hydrogels, such as polyacrylamide and 
polyethylene glycol (PEG) hydrogels  (Nisbet  et al., 2008, Straley  et al., 2010). Synthetic 
hydrogels have some notable advantages over natural hydrogels, namely adjustable 
mechanical properties, as well as easy control of scaffold structure and chemical 
composition.  So, 3D systems seem to be a good alternative. As explained above, most of 
the studies in the glial scar formation are in vivo studies in spinal cord injury. Few studies 
were done in ischemic brain injury models in vivo. On the other hand, signaling pathways 
involved in glial scar formation have been studied in classical 2-D astroglial culture (Wanner 
et al., 2008, 2013). To our knowledge, there are not reports studying glial scar formation 
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             General aim: 
To contribute to the study of the intracellular pathways involved in glial scar formation 
after ischemia to evidence potential pharmacological targets for future therapeutic 
intervention. 
 
           Hypothesis: 
The presence of blood-infiltrating cells and the gradient of DAMPs released from ischemic 
core are able to induce the glial scar formation by reactive astrocytes. These mechanisms 
could probably involve NF-B activity. 
 
      Specific aims: 
 
Specific Aim I: To evaluate glial scar formation in vitro using meningeal cells and astroglial 
2D co-cultures. Mixed primary glial cell cultures including astrocytes, microglia and 
oligodendrocytes obtained from Wistar rat pups were grown in the classical 2D culture 
plates and incubated with meningeal cells obtained from rat pups. Glial cell clustering and 
morphology was analyzed by live image time-lapse microscopy and immunocytochemistry.  
Specific Aim II: To evaluate glial scar formation in vitro using activated macrophages 
obtained from ischemic explants and naive astroglia. Mixed primary glial cell cultures 
including astrocytes, microglia and oligodendrocytes obtained from Wistar rat pups were 
grown in the classical 2D culture plates and incubated with explants obtained from wild type 
or GFP transgenic rats subjected to ischemia. Glial scar formation in vitro and sensitivity to 
NF-B blockage was tested.   
Specific aim III: To evaluate glial cell viability, morphology and reactivity in 3D collagen or 
3D nanofiber scaffolds. Mixed primary glial cell cultures including astrocytes, microglia and 
oligodendrocytes obtained from Wistar rat pups were grown in the 3D matrixes and glial cell 
viability and morphology was analyzed by live image time-lapse microscopy and 
immunocytochemistry with glial markers.  
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Specific Aim IV: Reproduction of ischemic penumbra and glial scar formation by controlled 
release of DAMPs into the matrix. One of the major hypotheses in glial cell biology after 
focal brain injury is that the gradient of DAMPs or other morphogens is able to induce the 
glial scar formation that surrounds the ischemic core and basically overlaps with the 
penumbra (Villarreal et al., 2014; Burda and Sofroniew, 2014). In this objective we 
performed focal injections of DAMPs or necrotic cell lysates in the 3D matrix with the mixed 
glia to induce a gradient of activation resembling the proposed gradient that occurs in 


















Raja Sekhar Mannava                                                IMBS                                                                                32 
 
                                                                    




















Raja Sekhar Mannava                                                IMBS                                                                                33 
 
                                                                    
 
Materials. Medium and reagents: Hank’s balanced Salt Solution (HBSS; Invitrogen-1644011), 
Dulbecco’s Modified Eagle Medium high glucose with glutamine (DMEM; Invitrogen-
119965092), Ham´s F-12 Nutrient mixture ( F-12; Invitrogen-1584933), 1:1 of DMEM and F-
12 (DMEM/F-12), penicillin/streptomycin (Sigma-P4333), poly-L-lysine (poly-L; Sigma-
P4707), 5- Fluorouracil (5-FU; Sigma-F6627), 0.05% trypsin, 0.25% trypsin, 0.2% (Sigma-
T6567), collagenase(Sigma-C5894), Fetal Bovine Serum (FBS; Natocor), Xylazine 
(Pharmavet), Ketamine (Richmond), BAY-11-7082 (Sigma), paraformaldehyde (Sigma-
P6148), Sucrose (Anedra-7118), Triton X-100, normal Equine Serum (Natocor). Primary 
antibodies: anti-GFAP (DAKO-Z0334), anti S100B (Sigma-S2532), anti TLR-2 and anti-TLR4 
(Santa Cruz- sc-16237 and sc-30002). Secondary antibodies: Alexa 594 (Red; Jackson-111-
585-144), Alexa 488 (Green; Jackson-111-545-144). Cellular staining: Tomato Lectin - 
Fluorescein isothiocyanate (Tomato Lectin-FITC; Sigma-L0401). Nuclear staining: 4l, 6-
Diamidino-2-phenylindole (DAPI; Sigma-D9542). 3D matrices: Collagen Solution, Type 1 from 
rat tail (Collagen matrix; Sigma-C3867), Hydromatrix (Sigma-A6982). Reagents used in 3D 
cultures: High Mobility Group Protein (HMGB-1; Sigma-H4652). 
 
Animals. Wistar strain rats were used from the animal facility of Faculty of Medicine of the 
University of Buenos Aires.  All rats were housed in a 12 h light/dark cycle in a specific 
pathogen free facility with controlled temperature and humidity and were allowed free 
access to food and water. All experiments were conducted according to protocols approved 
by the Comité Institucional para el Cuidado y Uso de Animales de Laboratario (CICUAL),  
from the faculty of Medicine of the University of Buenos Aires. These protocols were 
developed according to the standards for care and use of experimental animals from the 
National Institutes of Health of the United States of America (NIH), and the 
recommendations of the Society for Neuroscience (SfN). 
 
Astroglial cell culture. Primary cultures were obtained from neonatal rat pups (P3-P5). 
Brains were removed, meninges were set aside, and cortices were dissected and dissociated 
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mechanically using scissors and a serological pipette in HBSS. When tissue was no longer 
visible, and after decanting for 1-2 minutes, the supernatant was transferred to a new 
centrifuge tube. This extraction was repeated twice. Following a 5 min centrifugation at 
1000 rpm, pellet was washed in DMEM supplemented with 10% FBS, 100 μg/ml 
penicillin/streptomycin (DMEM complete) and platted in poly-L-lysine coated culture flasks. 
When the cells reached a state of confluence (8-10 days), flasks were closed tightly and 
wrapped in a ziploc sprayed with alcohol. Approximately 7ml of fresh medium was added to 
the flasks , making sure the lid remained dry during agitation. Flasks were agitated at 180 
rpm for 24 h, and the medium was removed and replaced by fresh complete medium. This 
procedure was repeated twice. After 48 h of agitation, 1 μl of mitotic inhibitor 5-FU was 
added per 8ml of fresh medium, and the flasks were further incubated for 24h. After 
incubation the medium with 5-FU was removed, and the cells were washed with 5ml of 
fresh complete medium to completely get rid of 5-FU. Finally, 10ml of fresh complete 
medium was added and cells were let to recover for 48 h. Cells were trypsinized (0.05%) for 
5minutes, and re-seeded in either 12 or 24 poly-L coated wells plates. For the experimental 
procedures, they were maintained in 5% CO2 at 37°C in complete DMEM. After 10-12 days 
in vitro (DIV) astrocytes reached confluence. 
 
 Isolation of meningeal cells. Cortical meninges from neonatal rat pups (P3-P5) were 
collected and placed in HBSS. For tissue dissociation, enzymatic digestion was performed 
with 0.25% trypsin, 0.2% collagenase, in HBSS for 30 min at 37OC. Mechanical disaggregation 
was performed sequentially with a P1000 and a P200 tip in the presence of 25U of DNase I. 
Washed cells were collected by 5 min centrifugation at 1000 rpm. The cell suspension from 
5 meninges was grown to confluence in DMEM/F12, 10% fetal bovine serum (FBS), 100 
μg/ml penicillin/streptomycin in a 3.5 cm diameter plate, previously coated with poly-L-
lysine for 7-10 days. 
 
Astrocyte meningeal co-cultures. Co-cultures were prepared by adding a suspension of 
15,000–30,000 meningeal cells to each well of confluent astrocytes prepared in a 24 well 
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plate. Co-cultures were incubated in DMEM/F12, 10% FBS, 100 μg/ml 
penicillin/streptomycin for 2–3 days. 
Cortical devascularization. Adult male Wistar rats (300-350 g) were obtained from the 
Animal Facility of the Pharmacy and Biochemistry School, University of Buenos Aires 
and transgenic rat strain [Wistar-TgN (CAG-GFP )184ys] (Mothe et al., 2005) was obtained 
from Dr. Fernando Pitossi (FIL, Buenos Aires, Argentina). Animals were housed in a 
controlled environment (12/12-h light/dark cycle, controlled humidity and temperature, 
free access to standard laboratory rat food and water) under the permanent supervision of 
a professional veterinarian. For all surgical procedures animals were anaesthetized with 
ketamine/xylazine (90/10 mg/kg i.p., (Intraperitoneally)). Animals were subjected to a 
unilateral cortical devascularization (CD) as previously described (Herrera and Robertson 
1989; Villarreal et al., 2011) making every effort to reduce the suffering and the number of 
animals used. Protocols were approved by the animal care committee CICUAL (Facultad de 
Medicina, UBA). 
 
Dissociated cell culture and explants from adult ischemic tissue. After recovery time of 3 
days post lesion (DPL), animals were deeply anaesthetized with ketamine/xylazine (90/10 
mg/kg i.p.) and sacrificed by decapitation. Brains were rapidly removed and placed 
in Dulbecco’s Modified Eagle Medium (DMEM) under sterile conditions. Meninges where 
then carefully removed and a very small region of the cortex containing the ischemic area 
(typically 2 mm x 2 mm x 2 mm) was dissected and placed in fresh DMEM. A similar 
fragment from an equivalent cortical area in the contralateral hemisphere was removed to 
be processed as control. Immediately after dissection, ischemic tissue was cut into four 
slices of similar size with a sterile blade and immediately each slice was plated in poly-L-
lysine coated dishes. Co-culture experiments of tissue explants on primary astrocytes were 
done essentially in the same way but explants were seeded on confluent astrocytes 
monolayer obtained from neonatal pups as described previously.  
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Cell culture fixation and immunocytochemistry. Cells were washed with phosphate-
buffered saline (PBS) 0.1M, and incubated in fixating solution (4% paraformaldehyde plus 
4% sucrose in PBS, pH 7.2) for 15 minutes at room temperature. After washing three times 
with PBS, cell permeabilization was achieved by using Triton X-100 in PBS (0.1%) for 15 min. 
After washing with PBS, cells were incubated for 30 minutes in blocking solution (containing 
normal Equine Serum 5% in PBS). Cells were then incubated overnight with primary 
antibodies diluted in blocking solution at 4°C. After washing 3 times with PBS, cells were 
incubated with secondary antibodies in blocking solution for 4 hours at room temperature. 
Cells were then washed 3 times with PBS, and were incubated overnight with Tomato Lectin 
at 4°C. Finally the cells were washed once with PBS, and incubated for half an hour with 
DAPI at room temperature for staining the nuclei of the cells. Primary antibodies used: anti-
GFAP (1/3000), anti S100B (1/1000), anti TLR-2 (1/1000) and anti-TLR4 (1/1000). 
Fluorescence immunocytochemistry was performed using secondary antibodies conjugated 
to Alexa 488 (green), Alexa 594 (red), and Tomato Lectin-FITC (1/1000) and DAPI 1μg/ml.  
 
Cell encapsulation in semisolid matrices. Collagen and Hydromatrix 3D matrices were 
tested for astrocytic viability and survival. While collagen matrix was not successful, 
Hydromatrix allowed cell survival for at least 45 days. Hydromatrix was used according to 
manufacturer’s specification. Briefly, a 2x Working Solution was prepared by adding 1 
volume of 10mg/ml Hydromatrix Stock Solution, 2 volumes of sterile 20% sucrose solution, 
and 1 volume of water. Cells were centrifuged and resuspended in DMEM containing 10% 
sucrose (w/v) (to protect cells from the low pH during gelification) at twice the final desired 
cell concentration. The 2x Working Solution was added to the 2x cell/sucrose mixture. Then, 
80μL of the mixture were added to each well of a 96-well plate. The gel formation was 
initiated by adding 1–2 volumes of medium to the side of each well. The gelification was 
usually completed after 1 h at 37°C. Tissue culture medium was added on the top of the gel 
and changed every two days.  
 
Injection of DAMP. When cells in the 3D matrix reached confluence, DAMPS were injected 
in to the matrix with the pipette tip at a point near to the wall of the each well. In control 
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wells, PBS was injected. DAMPS used: Astrocyte lysate (5μl/well) and HMGB-1 (5 μl/well). 
Astrocyte lysate is prepared by lysis of astrocytes by osmotic shock, followed by 
centrifugation for 5min at 1000rpm. The supernatant solution is used as astrocyte lysate. 
3D cultures immunocytochemistry. Cells were fixed with 30 minutes of incubation with 4% 
paraformaldehyde plus 4% sucrose in PBS pH 7.2 at room temperature. After washing with 
PBS, 6 times over 15 minutes, cell permeabilization was achieved by using Triton X-100 in 
PBS (0.1%) for 30 min. After washing with PBS double times to the normal protocol cells 
were incubated in blocking solution containing normal Equine Serum (5%) in PBS for 1 hour. 
Cells were then incubated 24h with primary antibodies diluted in blocking solution. After 
washing 5 times with PBS over 15 minutes, cells were incubated with secondary antibodies 
overnight in blocking solution.  
 
Photomicrographs. Pictures were taken with an Olympus IX-81 microscope equipped with a 
DP71 cooled camera. 
 
Quantitative studies. Total area occupied by Astrocyte free area (AFA) was quantified with 
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Primary meningeal cells induce retraction of astrocytes in culture:  
To overcome some of the problems associated with the study of the different 
molecules and cellular pathways involved in glial scar formation in vivo, we used meningeal 
cells to induce astroglial scar like structures in confluent astrocyte cultures in vitro as was 
reported by Wanner and colleagues (Wanner et. al; 2013). 
For that purpose, astrocytes were cultured to confluence and meningeal cells 
extracted from 3-5 days old rat pups were separately cultured for 15 days. Following this 
period, meningeal cells were added to the confluent astrocyte cultures (as described in 
Materials and Methods), and the co-culture was followed by time lapse microscopy under 
phase contrast. After 3 days, the co-cultures were fixed and immunocytochemistry was 
performed. Astrocytes were identified by glial fibrillary acidic protein (GFAP) 
immunostaining, while meningeal cells were labeled with fluorescent tomato lectin.  
Time lapse studies over 3 days revealed that, starting on day 1; astrocytes were 
gradually retracting away from central meningeal cell, forming circular areas that we named 
astrocyte free areas (AFA). Over time, some of the AFA coalesced to form larger AFA. We 
calculated the total surface area of these AFA per well at different meningeal cell 
concentrations: 15,000 or 30,000 meningeal cells/well. We observed that doubling the 
number of meningeal cells did not produce a significant change in the surface covered by 
the AFA (Figure 8). 
 
Figure 8. Total surface area of AFA 
per well at 2 different meningeal 
cell concentrations. Doubling the 
number of meningeal cells (30,000 
meningeal cells per well), did not 
produce a significant increase in 
AFA compared to the AFA in the 
wells that contained 15,000 
meningeal cells. 
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In order to study the morphology of the astrocytes corralling the meningeal cells, we 
performed immunocytochemistry on the co-cultures after 3 days of incubation with 
meningeal cells. The images revealed the classical corral-like structure of these AFA with 
isolated tomato lectin positive cells located in the AFA. Astrocytes were forming a circular 
structure of GFAP positive filaments with intermingled projections forming a scar-like 
structure (Figure 9). In addition, astrocytes showed an intense fibrilar GFAP staining and 
stellated morphology that is classically considered as the consequence of reactive gliosis in 
vitro. In the same images, weak tomato lectin labeling was observed on GFAP+ astrocytes, 
probably due to their reactive gliosis state induced by the presence of meningeal cells 







As evidenced by DAPI nuclear staining, there is a very low cellular density in the AFA, 
with almost no cells showing GFAP reactivity. On the other hand, GFAP positive areas have a 
very high cellular density and a healthy status without showing images of degenerating cells 
or pyknotic nuclei (Figure 10). 
Figure 9. Meningeal cells, astrocyte free areas (AFA) and reactive gliosis in 
primary astrocytic culture. Meningeal cells are strongly tomato lectin positive 
and do not express GFAP. They are present in AFAs induced in confluent 
astrocyte monolayers (A, B). GFAP staining in red, Tomato Lectin in green, and 
nuclei stained with DAPI in blue. Scale bar: 200 μm. 
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Barrier-forming astrocytes resemble glial scar forming astrocytes seen in vivo after a focal 
ischemic or traumatic brain injury: 
After closer observation of the astrocytes forming the astroglial scar like structures in 
vitro, we decided to compare them with the astrocytes forming astroglial scar in vivo.  
Following traumatic or ischemic injury to the brain, astrocytes become activated and 
surround the ischemic core forming a glial scar. The activated astrocytes forming in vivo glial 
scars are different to the normal astrocytes in their morphology and protein expression 
profiles (Amat et al., 1996). 
To evaluate if these in vitro astrocytes surrounding the AFAs induced by meningeal 
cells were similar to those observed in vivo, we performed immunocytochemical studies and 
a detailed observation of the astrocytes surrounding the AFAs. We observed that AFA were 
surrounded by a layer of high density, clustered, packaged overlapping and intermingled 
astrocytes (Figure 11). The astrocytes limiting the AFAs surrounding the meningeal cells 
showed cellular hypertrophy and had elongated cellular processes with extensive 
overlapping with the adjacent astrocytes perpendicular to the direction of their migration, 
particularly with the astrocytes on either side (Figure 11). Higher magnification images 
Figure 10. Astroglial corral-like like structures. Image on the left showing the 
astroglial corral-like structures. Image on the right shows DAPI nuclear staining to 
evidence the cell distribution. GFAP staining is shown in green and DAPI in blue. Scale 
bar: 200 μm. 
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showed that GFAP filaments were intermingled showing a wall-like structure similar to that 








Figure 11. Morphology and density of astroglial scar like structure. Astrocytes forming the 
borders of astroglial scar like structure are hypertrophied, and have highly elongated 
processes, and great overlapping. The processes run over the scar border. A,B: higher and 
lower magnification respectively; C: Image shows clustered and highly overlapping 
astrocytes at the border and confluent astrocytes, deep from border; D: Image shows DAPI 
nuclear staining allows visualization of astrocyte clustering, higher density of nuclei 
(astrocytes) at the scar like structure compared to the nuclei (astrocytes) distant from AFA. 
GFAP staining in green (A,B), red (C) and DAPI in blue. Scale bar: 200 μm.  
Raja Sekhar Mannava                                                IMBS                                                                                43 
 






Figure 12, also shows that astrocytes located more distant from the central 
meningeal cells were confluent with high degree of overlapping, and presented cellular 
hypertrophy resembling reactive glia distal to focal CNS injury. We conclude that the 
astrocytes forming astroglial scar like structure in-vitro had similarities with glial scar in vivo. 
 
Scar forming astrocytes have differential expression of TLR, GFAP and S100B:  
Taking into consideration the fact that scar forming astrocytes have shown a more 
activated phenotype, we decided to evaluate if there was heterogeneity in the expression of 
some proteins related to astrocyte activation as the distance from the meningeal cells 
increased. For that purpose, we performed immunocytochemical studies with specific 
antibodies to TLR2 and TLR4, two pattern recognition receptors related to innate immunity 
responses in the CNS. This study revealed that astrocytes forming the scar-like structures in 
vitro showed increased expression of TLR2 (Figure 13) and TLR4 (Figure 14). The TLR2 and 
TLR4 protein expression of astrocytes was inversely proportional to the distance from the 
meningeal cells: as the distance of astrocytes from the central meningeal cells increases the 
protein expression decreases. 
Figure 12. Morphology and density of astroglial scar-like structure. High magnification 
images showing the detailed organization of the glial scar-like structures in the borders of 
the AFA. Note that astrocytic retraction is not absolute and long projections persist into 
the AFA. 
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S100B is an astroglial protein that can behave as a DAMP activating pattern 
recognition receptors and inducing reactive gliosis in vitro and in vivo (Villarreal et al., 2014). 
In addition, it has been shown that astrocytes increase S100B expression and S100B 
controlled release when they are reactive in vitro and in vivo (Ramos et al., 2004; Gerlach et 
al., 2006). In agreement with the reactive state that we observed in scar-forming astrocytes, 
images show these astrocytes also express increased S100B protein (Figure 14).  
We conclude that, even though all the astrocytes are activated or reactive, the 
astrocytes forming the scar-like barrier had distinctive morphological and probably different 




   
Figure 13. Expression of different proteins associated with astrocyte activation. 
Astrocytes forming the astroglial scar like structure showed increased GFAP and TLR2 
expression. The expression decreases with increasing distance from the menigeal cells. 
(A,B, lower and higher maginfication respectively). GFAP staining in green and TLR2 in 
red, and nuclei in blue with DAPI. Scale bar: 200 μm. 
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Biochemical pathways involved in glial scar formation in vitro: 
The initial active displacement of astrocytes from the areas where meningeal cells 
are located, and the subsequent change in astroglial cell polarization from the stellated 
shape to a wall-like structure with intermingled projections are intriguing proccesses.  
Having in mind the differential expression of TLR2 and TLR4 receptors in the scar-forming 
astrocytes, we evaluated if the TLR downstream effector NF-B could be involved in the 
cellular pathways leading to scar formation in vitro. 
For that purpose, we used the cortical devascularization model of brain ischemia 
(Ramos et al., 2004; Villarreal et al., 2011, 2014) in GFP-expressing rats ([Wistar-TgN(CAG-
GFP)184ys]) (Mothe et al., 2005), and 3 days after the ischemic injury we obtained ischemic 
tissue explants from brain cortex. These cortical ischemic tissue explants were cultured 
alone or co-cultured over confluent astrocytic cultures and followed by live imaging time-
lapse microscopy.  
Figure 14. Differential protein expression by the astrocytes. Astrocytes at the border of 
AFA are highly elongated with high expression of TLR4 and S100B, while the astrocytes 
that are distant from the meningeal cells, TLR4 stained, had lower expression of TLR4 
and S100B and were confluent. (A,B lower and higher magnification respectively). TLR4 
staining in green and S100B in red. Scale bar: 200 μm. 
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Ischemic cortical explants, but not explants obtained from the contralateral 
hemispheres, released a large number of cells morphologically identified as macrophages 
activated by the ischemic injury (Figure 15). 
 
When the ischemic explants were co-cultured with astrocytes, we observed that 
astrocytes retracted from the areas occupied by macrophages resembling the effects 
observed in meningeal cells-astrocytes co-cultures (Figure 16). 
 
 
Figure 15: Low magnification 
images showing the escape of 
activated macrophages from 
ischemic tissue explants that 
are absent in similar explants 
of the contralateral (control) 
hemisphere. Images were 
taken after 1 day in vitro.  
Figure 16: Ischemic explants cultured over astrocytes. Low magnification images showing the 
escape of activated GFP+  (green) macrophages from ischemic tissue explants  that induce the 
scar-like structures in the confluent astrocytic monolayer. The place where ischemic explant was 
placed is indicated by the asterisk (*). Images were taken after 5 days in vitro, and explants were 
from ischemic animals of 3 days of recovery time.  
* 
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In order to study the role of NF-B in the formation of glial scar in vitro, we 
performed a loss of function experiment by repeating the same paradigm, but pre-
incubating astrocytes during 1 h with the NF-B inhibitor BAY-11-7082 to block NF-B 
activation in the astrocytes that will receive the explants. 
As shown in Figure 17, NF-B blockage in the astrocytic monolayer induced a 
reduced retraction of the astrocytic monolayer. We conclude that macrophages activated by 
ischemia in vivo are highly mobile and induce astroglial retraction. The astroglial retraction 
from the area occupied by macrophages, as the initial step for glial scar formation, requires 






Astrocytes growing in 3D cultures are also sensitive to DAMPs gradients, but do not form 
scars: 
After culturing the astrocytes to confluence in 3D hydrogel matrices during 16 days, 
we injected recombinant HMGB-1 as a DAMP or  soluble astrocyte lysate in the gel. The 
purpose of this experiment was to test the astroglial response to a focal  DAMP  release that 
would mimic the situation of the ischemic core. In the ischemic core in vivo, neuronal 
necrotic cell death induce a focal source of DAMP that reach the astrocytes and probably 
Figure 17: A: Scar formation requires NF-B. Ischemic cortical brain explants 
cultured on a confluent astrocytic monolayer showed the reduced distance 
reached by the astroglial scar. B: Quantitative analysis of the maximal distance at 
which the glial scar is formed after 3 and 5 days in vitro. Statistical significance 
was tested by one way ANOVA and Student Newman Keuls post-test. 
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contributes to glial scar formation. Using the nanotube Hydromatrix matrices, astrocytes 
grow in a more realistic 3D environment, and survive for several weeks with excellent 
viability (Figures  18, 19). After injecting the DAMPs, cultures were followed by time lapse 
microscopy during 3 days and then they were fixed. Immunocytochemistry revealed that 
astrocytes growing in 3D culture were sensitive to DAMPs and responded with reactive 
gliosis and increased GFAP expression. However, we could not find scar-like structures 
assembled by astrocytes (Figure 20). In another set of experiments, we used mixed glia 
(microglia plus astrocytes) and no scar formation was observed. We conclude that a focal 










Figure 18. Three dimensional growth of astrocytes in hydromatrices. The astrocytes 
cultures in Hydromatrices showed morphology with growth in three dimensions as 
shown by arrows, similar to the in vivo astrocytes, and they are also cultured for 
longer times compared to 2D (or astrocytes have longer life span in 3D cultures 
compared to the 2D cultures). Scale bar: 50 μm. 
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Figure 20. Sensitivity of 3D astrocytes to recombinant pure DAMP (HMGB-1), or mixed DAMPs 
(soluble glial lysate obtained by osmotic shock). Reactive gliosis is induced by the DAMP 
injection but no glial-scar structures were observed. The astrocytes were immunostained by 
GFAP and the pictures shows increasing magnification from top to bottom. GFAP staining in red. 
Site of injection is shown by an asterisk (*). Scale bar: 200 μm. 
Figure 19. Morphology and distribution of astrocytes in 3D hydromatrices. Astrocytes in 3D 
have fine philopodia and round cell body compared to the 2D monolayer astrocytes. Reaching 
the confluence is not possible for astrocytes growing in 3D matrixes. The astrocytes in 3D are 
maintaining their territory compared to the astrocytes in 2D, where astrocytes have intense 
overlapping after reaching confluence. GFAP staining in red. Scale bar: 200 μm  
* * 
* 
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We initially reproduced the technique detailed by Wanner and colleages (2013) to 
induce in vitro glial scar formation in the confluent astrocytes culture by the addition of 
primary meningeal macrophages. In spite of the fact that we used two meningeal cell 
concentrations (30,000 meningeal cells per well and 15,000 meningeal cells per well), we 
noticed that there is no significant increase in the total AFA even though we doubled the 
meningeal cells per well. This is an intriguing result that is probably reflecting that, after 
certain number of meningeal cells, there will be no further increase in total AFA per well as 
the astrocyte enzymes involved in astroglial migration away from the macrophages will get 
saturated. Alternatively, it might be also possible that, in spite of having higher level of 
soluble mediators secreted by macrophages, there might not be further free migration of 
the astrocytes because of the crowding of the astrocytic monolayer.  
For glial scar formation, it is critical to understand the molecular machinery 
governing astrocyte polarity and recruitment to the injury site (as the case of NG2 glial cells) 
or the migration away from the ischemic core (astrocytes). The Rho family of small GTPases, 
mediate the convergence of both extracellular and intracellular signals onto the 
cytoskeleton, resulting in morphological plasticity (Abbracchio et al., 1997, Chen et al., 
2005). The small RhoGTPase Cdc42 has emerged as a key regulator of polarization, 
influencing directional migration in cultured fibroblasts and astrocytes. After interaction 
with its prototypic ligand High-Mobility Group Box 1 (HMGB-1), RAGE regulates cell 
migration by activating Rac1 and Cdc-42 signaling (Taguchi et al. 2000; Bassi et al. 2008; 
Hudson et al. 2008).  
The laboratory of my director also showed that changes in astroglial cytoskeleton 
leading to the stellated reactive astroglial phenotype and the migration towards cell free 
areas in vitro share the RAGE/Cdc42-Rac1 pathway (Villarreal et al., 2014). The initial event 
in astroglial migration was the astroglial polarization towards the injury site and the 
subsequent protrusion of long processes. These processes exhibit a flattened polygonal 
shape in their distal end, similar to philopodia and very similar to those observed in our 
present results in scar-forming astrocytes. However, most of the literature on astroglial cell 
migration was obtained by the analysis of scratch assays. While scratch assays induce 
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astroglial migration towards a cell-free area, a process that is facilitated in vitro due to loss 
of contact inhibition, migration away from macrophages or from the ischemic core involves 
the override of cell contact inhibition and probably even detaching from the culture surface. 
Even though this is an extremely stressful situation for cells in culture, we could not observe 
images of pyknotic nuclei or degenerating cells. Based on the available information and our 
present observations, we speculate that small RhoGTPases Cdc42 and Rac1 would be crucial 
for astrocyte polarization required for glial scar formation.  
Most of the glial scar studies are done in spinal cord injury (SCI) models. After SCI 
crush, the reactive astrocytes that are more distant (> 1mm) from the large central lesion 
core, exhibited a clear and pronounced upregulation of GFAP and some somatic 
hypertrophy. Nevertheless, these reactive astroglia retained both their basically stellate 
appearance with GFAP and their basic bushy appearance. In contrast, astroglia in scar 
borders immediately adjacent to central lesion core, exhibited distinctive elongated 
morphologies with overlapping and interacting processes. With increasing distance from 
lesion borders, reactive astroglia transitioned in a clearly graded fashion to morphologies 
more similar to those seen in healthy tissue. In our in vitro experiments we demonstrated 
this striking differences between glial scar forming astrocytes (astrocytes forming the border 
of AFA), and the the astrocytes that are distant from lesion (AFA) as seen in vivo glial scar. 
We noticed the formation of well-organized glial scar with highly elongated, overlapping and 
interacting process. The astrocytes distant from the area occupied by macrophages retained 
the normal stellate morphology being confluent with less overlapping. We also noticed that 
the astrocyte forming the border of AFA have projections towards the center of the AFA, 
which might be because of the incomplete retraction of astrocytes forming the scar. 
However, we can also interpret that, as the border seems to be well formed and organized, 
these processes have the role of sensing the molecular environment in the AFA in vitro or in 
the lesion core in vivo.      
Toll-like receptors (TLR) are one of several classes of pattern-recognition receptors 
(PRRs), which are involved in the activation of the innate immune system and the 
subsequent orchestration of the adaptive immune response (Kaisho and Akira, 2006; 
Medzhitov and Janeway, 2000). Upon recognition of conserved molecular motifs expressed 
by PAMPs or DAMPs, TLRs initiate a cascade of intracellular events involving the Nuclear 
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Factor kappa B (NF-B)-dependent production and release of cytokines and chemokines 
(Hirschfeld et al., 1999; Medzhitov et al., 1997). DAMPs can bind and trigger TLR activation 
and consequently contribute to sterile inflammation. Some DAMPs are confined to the 
intracellular space under physiological conditions, and are released into the extracellular 
space following injury- or disease-induced cellular damage and death. These DAMPs include 
HMGB-1 (Park et al., 2004), heat shock proteins (HSPs) (Asea et al., 2002; Ohashi et al., 
2000), microRNA (Lehmann et al., 2012), mitochondrial RNA and DNA (Kariko et al., 2005; 
Zhang et al., 2010) and histones (Huang et al., 2011). 
HMGB-1 is a DNA binding protein that regulates gene transcription. In pathological 
conditions, HMGB-1 is passively released by damaged and necrotic cells or actively released 
by activated inflammatory cells (Scaffidi et al., 2002). It is increasingly clear that TLRs do in 
fact play a role in ischemic damage, especially TLR2 and TLR4 have been shown to play a 
role in cerebral ischemic damage (Marsh et al., 2009). Following ligand binding, TLRs form 
homodimers (Bovijn et al., 2012) or heterodimers (Hajjar et al., 2001; Ozinsky et al., 2000) 
and initiate signaling through either the myeloid differentiation 88 (MyD88)-dependent or 
MyD88-independent pathways (Akira and Takeda, 2004). Injury to the CNS induces an 
increase in the expression of TLRs and their downstream effectors (Kigerl et al., 2007), 
leading to the generation of inflammatory mediators such as TNF, IL1, IL6, and iNOS, all 
known to be associated with stroke damage (Marsh et al., 2009).  
As previous studies show increasing importance of TLR in ischemic injury, we decided 
to test the expression of TLR by the scar forming astrocytes. We tested the TLR expression in 
the model of glial scar formation by the primary meningeal cells (Wanner et al., 2013). We 
noticed the increased expression of TLR2 and TLR4 in scar forming astrocytes, while the 
remaining reactive astrocytes presented lower expression.  Based on our results we can only 
speculate on the causes of such differential expression. While scar-forming astrocytes are 
exposed to high levels of DAMPs in vivo and it is known that DAMP can initiate a feed-
forward loop to increase TLR and RAGE expression (Villarreal et al., 2014; Pelham et al., 
2014); this could not be the case in vitro. However, it is plausible that macrophages secrete 
acetylated HMGB-1 (Liesz et al., 2015) that could exert such feed-forward autocrine loop by 
activating the NF-B responsive elements in TLR promoters. An alternative explanation is 
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that scar-forming astrocytes are the more reactive phenotype and thus it is expected that 
they present higher expression levels of proinflammatory mediators like TLR.    
In the central nervous system (CNS), the transcription factor nuclear factor NF-B is a 
key regulator of inflammation and secondary injury processes. In CNS trauma, the first 
phase of damage, dependent on mechanical destruction of the nervous tissue, is followed 
by a secondary phase caused by severe local disturbance of the blood supply and a massive 
release of pro-inflammatory mediators and neurotoxins from invading and resident cells 
(Schwab et al., 2002). A prominent source of inflammatory mediators is astroglia, which, in 
response to injury, undergoes a profound activation known as reactive astrogliosis (Ridet et 
al., 1997). Even though reactive astrocytes release factors essential for neuronal survival 
and wound healing (Faulkner et al., 2004), they are also responsible for the production of 
molecules detrimental to functional recovery and for creating an environment unfavorable 
to nerve regeneration (Menet et al., 2003).  
Many of the processes occurring in reactive astrocytes as a consequence of CNS 
damage are regulated by NF-B (O’Neill et al., 1997). After brain injury, NF-B is highly 
activated (Bethea et al., 1998, Beni et al., 2004) and the expression of NF-B–dependent 
genes is up regulated (Bethea et al., 1999, Siren et al., 2001), indicating a critical function of 
this factor in CNS pathophysiology. NF-B is an important transcription factor downstream 
in the TLR2, TLR4 and RAGE-mediated signaling pathways which respond to a variety of 
stimuli (Toshchakov et al., 2002).  
In unstimulated cells, NF-B proteins are sequestered in the cytoplasm by IB 
inhibitory proteins. Various immune stimuli induce the IB kinase (IKK) to phosphorylate 
IBs, triggering their ubiquitination and degradation. Released NF-κB dimers are further 
activated through various posttranslational modifications and translocate to the nucleus 
where they bind to specific DNA sequences and promote transcription of target genes.  The 
transcription factor NF-B is a key regulator of hundreds of genes involved in cell survival 
and inflammation (Hayden et al., 2008). 
Having in mind that TLR2 and TLR4 were overexpressed in scar-forming astrocytes in 
vitro, we hypothesised that NF-B may play crucial role in glial scar formation and 
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maintenance. Following our hypothesis we tested the effect of NF-B on glial scar formation 
induced by ischemia-activated macrophages. By using ischemic cortical brain explants co-
cultured over a confluent astrocytic monolayer, we observed a dense compact glial scar 
formation after 3-5 days in vitro. When astrocytes receiving the ischemic explants with 
activated macrophages were pre-treated with the NF-B blocker BAY 11-7082 for 1 h, we 
observed a reduced migration of astrocytes away from the ischemic tissue. Furthermore, we 
also observed that the thickness of the glial scar was less compact when NF-B activation 
was blunted. Hence, we conclude that NF-B plays a crucial role in the astroglial response 
that leads to the glial scar formation induced by ischemia-activated macrophages.  
Immunohistochemical studies from the cortical ischemic injury of cortex showed, 
astrocytes with STAT3 and NF-B activation as soon as 2 to 4 hours post-lesion, preceding 
cell hypertrophy and GFAP up regulation, and being maintained in the long-term formed 
glial scar (Acarin et al., 2000). From previous studies (Wanner et al., 2013) and from the 
group of my director, we know that both NF-B and STAT3 pathways play important roles in 
cell migration, immune cell activation inflammation and astroglial hypertrophy. The present 
results blocking NF-B, and those obtained by Wanner and colleages (2013) blocking STAT3 
in vitro and in vivo, show that blockage of these pathways does not prevent the formation 
of the glial scar but reduces its quality. In fact, we observed that the cell density of the scar 
and the distance from the macrophages is reduced after NF-B blockage and STAT3 knock-
out mice show increased invasion of blood derived leukocytes after SCI (Wanner et al., 
2013). So far, we consider it is probable that the NF-B and STAT3 pathways act in parallel, 
and probably synergistically to assembly or maintaining the scar.      
Cells cultured in 3D matrixes exhibit features that are closer to the complex in vivo 
conditions (Vinci et al., 2012). In conventional 2D conditions, the extracellular matrix 
components, cell-to-cell and cell to-matrix interaction that are important for differentiation, 
proliferation and cellular functions in vivo are lost (Mazzoleni et al., 2009). The “closer-to-in 
vivo” behavior of cells when grown as 3D cultures is mainly because of the matrices and 
scaffolds that are used for obtaining such cultures. These matrices and scaffolds mimic the 
native extracellular matrix by porosity, fibrous, permeability and mechanical stability. The 
micro architecture enhances the biophysical and biochemical interaction of the adhered 
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cells to be better expressed in vitro. The 3D matrix provides a biologically active 
environment for the cells to proliferate, differentiate and secreted cell specific extracellular 
matrix. The choice of such matrices and scaffolds is based on cell type and the nature of the 
study. Also, the pore size, ligand density and stiffness can be varied easily, and thus making 
it easy to change the structural properties of the gel (Baker et al., 2009, 2011; Harjanto and 
Zaman, 2011). Thus, 3D culture models have proven to be more realistic for translating the 
study findings for in vivo applications.  
The cell culture dimension from conventional 2D monolayer to a 3D setting leads to 
down regulation of astrocyte activation markers, indicating that astrocytes in 3D are less 
reactive than their 2D counterparts, thus resembling the physiological in vivo situation and 
providing the first ‘ground state’ system in which triggers of astrogliosis can be investigated 
(East et al., 2009). As the movement of cells into or within biomaterial scaffolds is a 
prerequisite for the studies on glial scar formation. In addition, as the hydrogels we are 
using for the 3D experiments are polypeptide polymers, using 3D matrices it would be more 
helpful in studying whether the astroglial migration through the matrices is proteolytic 
(mesenchymal) migration with the involvement of matrix metalloproteases (MMP´s) or non-
proteolytic (amoeboid) migration.  
Flow-cytometry data shows cells in 3D matrix had more cells in G0/G1 phase and 
fewer cells in S phase (Ravi et al 2015). In our experiments, astrocytes cultured in the 
Hydromatrix,  reached the confluence slowly compared to the 2D counterparts and also 
hydromatrix allowed cell survival for at least 45 days without reseeding the cells. This might 
be attributed to the property of hydrogels to keep cells hydrated and nourished for a longer 
time along with providing attachment and development support. Thus, cells grown in 
matrices instead of as monolayers, are able to survive for extended time and at slower 
proliferation rates which is pretty much closer to the in vivo scenario.  
The key morphological differences that we observed are that cells in 2D had larger 
cell area and flattened morphology with wider philopodia compared to astrocytes in 3D 
matrix. Astrocytes in 3D have fine filopodia and are generally rounder and had a smaller cell 
area. Also, even when the astrocytes reach the confluence in 3D are maintaining or well 
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within their territory compared to the astrocytes in 2D where astrocytes have some 
overlapping after reaching confluence. 
After the treatment with DAMPs (astrocyte lysate or recombinant HMGB-1), 
astrocytes appeared considerably more ramified compared to control cultures at the same 
time points. As we have injected the DAMPs at one border of the well, we noticed the 
graded response of the astrocytes to the treatment. The astrocytes that are close to the site 
of injection had high GFAP expression, they were hypertrophied with long and elongated 
process stretching in to the surrounding astrocytes territories compared to the astrocytes 
that are distant from the site of injection, where astrocytes have little elongations. 
Astrocytes showed signs of migration with small cell free area and alignment of the 
elongated cellular process away from the site injection that is towards their direction of 
migration, especially in the wells where astrocyte lysate was injected. The astrocytes 
treated both with the pure DAMP, HMGB-1, or the DAMP mixture (astroglial cell lysate) 
showed the morphological features of reactive and reoriented astrocytes with highly 
polarized phenotype and highly elongated processes, except that there is no clear scar 
formation with interacting and overlapping filaments perpendicular to the direction of their 
migration. The astroglial polarization and reoriented cytoskeleton, but lacking of glial scar 
formation can be interpreted in different ways. It is plausible that technical variations, 
including the requirement of longer incubation times could be required for 3D cultures 
compared with 2D or the quality of the DAMP gradient in the matrix compared with the 
native gradient in vivo, could account for the lack of glial scar formation in vitro in 3D 
hydromatrixes. On the other hand, when we compare the in vivo glial scar formation, the 
successful scar formed in 2D macrophages-astroglial co-culture and the dense scars 
obtained in 2D ischemic explants-astroglial co-culture, it is clear that macrophages and 
cytokines derived from them are missing in 3D cultures. Thus, these results stress the fact 
that activated macrophages and DAMPs are probably required to form a glial scar that 
resemble those found in vivo after ischemia or SCI.  
In summary, our results show that intracellular pathways and molecules involved in 
glial scar formation can be studied in vitro using different approaches in 2D or 3D platforms. 
Based in our findings, we conclude that NF-B is required for the glial scar formation and 
this transcription factor probably lies downstream of the TLR2 and TLR4 innate immunity 
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receptors that are overexpressed by scar-forming astrocytes. Finally, we were unable to 
produce glial scars when we used a focal release of recombinant HMGB-1 (a pure synthetic 
DAMP) or soluble cell lysate (mixed DAMPs) probably due to the absence of macrophages 
and/or cytokines produced by these cells.  
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